English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Isagro sales posted a 20% increase in H1 2014qrcode

Aug. 6, 2014

Favorites Print
Forward
Aug. 6, 2014

For the first half of 2014, the sales of Isagro was characterized by a strong recovery. The sales jumped by 20.1% to €72.9 million and EBITDA soared up by 346.3% to €6.9 million, versus €1.5 million in the first half of 2013. EBIT recorded around €2.6 million, versus €3.3 million loss at the same period of 2013. 

The sales of first half of 2013 was negatively affected by the “carried-over” effect of 2012 drought that hit some markets of great relevance for Isagro, and by the start of the commercial cooperation with the partner Gowan in the US and in Italy.

Isagro sales results (€000)
ended June 30
First half 2014
First half 2013
Change %
Sales
72,934
60,697
20.1
EBITDA*
6,900
1,546
346.3
EBIT** (loss)
2,567
(3,314)
-
* earnings before interest and tax depreciation and amortisation
** earnings before interest, tax










Outlook

In the light of the achievement of 2014 first half expected results, Isagro confirms the reasonableness of the targets of Revenues (around €150 million) and EBITDA (around €15 million) set for the current year and contained in the Business Plan 2014-2018.

 

0/1200

More from AgroNewsChange

Hot Topic More

Subscribe Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe AgroNews Daily Alert to send news related to your mailbox